Clearpath Bio provides digital twins of bioreactor systems, enabling manufacturers to reduce batch cycle times by 12-18%. The UNSW-spun team works with CSL and several CDMO players across Australia and Singapore. Their ML-driven optimisation layer has become the standard for GMP-compliant facilities seeking regulatory approval acceleration.